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The Spemann Organizer Signal noggin Binds
and Inactivates Bone Morphogenetic Protein 4
Lyle B. Zimmerman, Jose´ M. De Jesu´s-Escobar, first identified by their ability to induce ectopic bone
development in mammals; BMPs have since beenand Richard M. Harland
Department of Molecular and Cell Biology shown to act as mesoderm ventralizers and epidermal
inducers in Xenopus assays, at theexpense of the dorsalDivision of Biochemistry and Molecular Biology
University of California mesoderm and neural tissue induced by the Spemann
organizer (Dale et al., 1992; Jones et al., 1992; FainsodBerkeley, California 94720
et al., 1994; Re’em-Kalma et al., 1995; Sasai et al., 1995;
Schmidt et al., 1995; Wilson and Hemmati-Brivanlou,
1995). Conversely, disruption of BMP signaling mimicsSummary
organizer activity: injection of mRNAs encoding domi-
nant negative BMP4 receptors or unprocessable BMPSignals released by the Spemann organizer of the
precursors induces neural tissue and dorsalizes meso-amphibian gastrula can directly induce neural tissue
derm (Graff et al., 1994; Mae´no et al., 1994; Suzuki etfrom ectoderm and can dorsalize ventral mesoderm to
al., 1994; Hawley et al., 1995; reviewed in Harland, 1994).form muscle. The secreted polypeptide noggin mimics
While noggin could be exerting its effects on BMPthese activities and is expressed at the appropriate
signaling via an independent signal transduction path-time and place to participate in the organizer signal.
way, it is suggestive that another TGFb, the potentNeural induction and mesoderm dorsalization are an-
mesoderm inducer activin, can be inactivated by hightagonized by bone morphogenetic proteins (BMPs),
affinity binding to a secreted protein, follistatin (Naka-which induce epidermis and ventral mesoderm in-
mura et al., 1990; Schneyer et al., 1994). By analogy,stead. Here we report that noggin protein binds BMP4
noggin protein could act by binding BMP4 directly, be-with high affinity and can abolish BMP4 activity by
fore it has reached its target, thus preventing it fromblocking binding to cognate cell-surface receptors.
transmitting its signal through its receptors. This modelThese data suggest that noggin secreted by the orga-
is supported by epistasis experiments in Drosophila,nizer patterns the embryo by interrupting BMP sig-
where no noggin equivalent has been identified. Injec-naling.
tion of Xenopus noggin RNA into fly embryos can block
the effects of the fly BMP2/4 homolog decapentaplegicIntroduction
(dpp), but noggin has no effect on embryos coinjected
with an activated mutant dpp receptor, suggesting thatIn Xenopus, the neural plate and the bulk of the somitic
its antagonizing activity is exerted upstream of the dppmesoderm are induced during gastrulation. Spemann
receptor (Holley et al., this issue of Cell).and others demonstrated that a signaling center at the
The opposing activities of noggin and BMP4 in thedorsal lip of the gastrula blastopore could direct neigh-
developing Xenopus embryo led us to examine whetherboring tissues to assume neural or dorsal mesodermal
noggin antagonized BMP4’s effects in other systems,rather than epidermal and ventral mesodermal fates (re-
whether there was a direct physical interaction betweenviewed in Hamburger, 1988). More recent work suggests
the two proteins, and whether this mechanism couldthat this Spemann organizer signaling center secretes
account for noggin’s ability to participate in Spemanna cocktail of polypeptides that induce both neural and
organizer signaling.dorsal mesodermal fates (Kessler and Melton, 1994;
Slack, 1994).
The first molecule shown to have the properties ex- Results
pected of a Spemann organizersignal, noggin, was iden-
tified in an expression screen for activities that induce noggin Blocks BMP4 Activity in a
Dose-Dependent Fashiondorsal structures in Xenopus embryos (Smith and Har-
land, 1992). noggin is expressed in the organizer at the The antagonism between the biological activities of nog-
gin and BMP4 in the Xenopus embryo could be complexgastrula stage and encodes a novel z32 kDa glycopro-
tein that is secreted as a homodimer. Soluble noggin and indirect; we therefore examined this interaction in
a direct, quantitative bioassay for BMP protein activity.protein mimics organizer activities in the induction of a
muscle marker in explants of gastrula ventral marginal The murine bone marrow stromal cell line W-20-17 re-
sponds to treatment with BMP4 protein by inducingzone that would otherwise be fated to form ventral
mesoderm (Smith et al., 1993). noggin also induces ante- alkaline phosphatase activity (Thies et al., 1992). Prein-
cubation of BMP4 with 16 nM noggin protein for 1 hrrior neural markers in animal cap ectoderm that would
otherwise become epidermis (Lamb et al., 1993). nog- abolishes its activity over a range of BMP4 doses from
0.1 pM to6.66 nM (Figure 1).noggin alone has a small butgin’s mechanism in Spemann organizer signaling re-
mained elusive, since no cell-surface receptor transduc- reproducible inhibitory effect in the absence of added
BMP4, suggesting that itmay antagonize activities pres-ing the noggin signal has been identified.
Organizer signals such as noggin may be antagonized ent in serum or secreted by the W-20-17 cells.
At lower concentrations, noggin inhibits the activityby members of the bone morphogenetic protein (BMP)
class of the transforming growth factor b (TGFb) gene of a molar equivalent of BMP4. At 420 pM BMP4, prein-
cubation with 160 pM noggin (38% of 420 pM) reducessuperfamily. These dimeric secreted glycoproteins were
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Figure 1. noggin Blocks BMP4 Activity in a Bone Marrow Stromal
Cell Line Assay in a Dose-Dependent Fashion
Induction of alkaline phosphatase activity was assayed in W-20-17
murinebone marrow stromalcells. Triplicate serial dilutions of BMP4
at 0, 100, 210, 420, 830, 1,660, 3,330, and 6,660 pM were preincu-
bated alone (squares) or with purifed human noggin at 160 pM
(triangles), 1,600 pM (circles), or 16,000 pM (diamonds) for 1 hr prior
to addition to cells. Alkaline phosphatase activity was assayed 24
hr later. At each point, noggin blocks a molar equivalent of BMP4 Figure 2. BMP4 Protein Associates With Immobilized noggin
activity.
COS supernatant containing myc-tagged BMP4 was incubated with
a Xenopus gastrula extract (as nonspecific competitor) plus either
noggin-coupled sepharose beads or control mock-coupled beads,specific alkaline phosphatase activity by 39%; at 830
washed, and then Western blotted with anti-myc antibody. BMP4-pM BMP4, 160 pM noggin (19%) inhibits 16% of the
myc immunoreactivity specifically associated with noggin-coupledactivity. This linear relationship between noggin dose
beads.and inhibition of BMP4 activity is consistent with a direct
interaction between the two proteins. Moreover, theper-
sistence of the linear dose-dependence at very low con- incubated with both sets of beads in the presence of
1 mg/ml of a Xenopus gastrula extract as nonspecificcentrations suggests that the affinity of noggin for its
effector (whether BMP4 or another molecule) in this sys- competitor (Figure 2). Beads were washed and analyzed
by Western blot for myc immunoreactivity. BMP4-myctem may be quite high. For example, if the Kd of noggin
for a “receptor” (not present in large excess) were 10 was observed to associate with noggin-coated beads
but not mock-coupled beads. Use of either gastrulanM, at 160 pM we might expect that only a small fraction
of the noggin present would be effective. Instead, 160 extract or bovine serum albumin (BSA) at 1 mg/ml (data
not shown) as nonspecific competitor did not interferepM noggin quantitatively inhibits BMP4 activity, consis-
tent with an affinity several orders of magnitude higher. with binding, suggesting that the interaction of noggin
and BMP4 is sufficiently specific to occur in the complex
biochemical environment of the gastrula, but is not de-noggin Protein Associates with BMP4
A simple model explaining noggin’s ability to inhibit pendent on the presence of auxiliary proteins.
BMP4 signaling in both Xenopus and mammalian cell
culture is one in which noggin protein binds BMP4 di- noggin Binds BMP4 with Very High Affinity
Many growth factors, including the BMPs, have veryrectly and prevents activation of its signal transduction
pathway. To test this hypothesis, we first analyzed high affinities for their receptors (Kd ≈ 1029 2 10210 M;
Koenig et al., 1994; Iwasaki et al., 1995). For noggin toBMP4’s ability to associate directly with noggin bound
to sepharose beads block BMP signaling effectively in our model, it must
either bind at least as tightly to or be present in largeTo facilitate identification and quantitation of BMP4
protein, we constructed a myc-tagged version of BMP4, excess over its target cytokine. To quantitate the affinity
of noggin for BMPs, we incubated a range of concentra-expressed it in COS cells, and confirmed that the super-
natants had biological activity. Xenopus noggin protein tions of purified human BMP4 and radioiodinated BMP4
tracer with a constant concentration of purified humanwas purified from transfected COS supernatant and, to
make it easier to manipulate, covalently bound to CNBr- noggin that had been fused to an immunoglobulin Fc
domain (hnogFc). noggin-BMP complexes were thenactivated sepharose beads. As a control for nonspecific
binding, another set of sepharose beads was subjected isolated by allowing hnogFc to bind directly to protein
G-sepharose beads, subjected to SDS–polyacrylamideto an identical coupling protocol in the absence of nog-
gin protein. BMP4-myc COS supernatants were then gel electrophoresis (SDS–PAGE), and the 125I-BMP4
noggin Binds BMP4 with High Affinity
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Figure 4. noggin Preferentially Binds BMP2 and 24
Fc-tagged human noggin was incubated with 125I-BMP4 alone
(5100% specific binding) or with serial dilutions (4, 8, 16, 31, 62,
125, 250, 500, 1,000, 20,000 pM) of purified human BMP4 (closed
squares), BMP2 (open squares), BMP7 (closed circles), or porcine
TGFb1 (open circles) and then precipitated and quantitated as in
Figure 2. BMP2 and -4 competed effectively with 125I-BMP4 for
Figure 3. noggin Binds BMP4 with High Affinity binding to human noggin. At higher concentrations, BMP7 was also
able to displace 125I-BMP4. TGFb1 did not compete for binding.Purified human BMP4 at 0 to 500 pM, with trace 125I-BMP4, was
incubated with Fc-tagged human noggin for 1 hr at 48C, precipitated
with protein G–sepharose, and quantitated by SDS–PAGE and
phosphorimager. Scatchard analysis (inset) yields an apparent Kd porcine TGFb1 (35%) were included as competitors,and
of 19 pM. the incubation was followed by precipitation and quanti-
tation as in the previous experiment. Following subtrac-
tion of nonspecific binding, bound counts at each con-
tracer was quantitated. Nonspecific binding was deter- centration of unlabeled ligand were expressed as a
mined by two methods: binding in the absence of percentage of the specific 125I-BMP4 counts bound to
hnogFc and binding in the presence of 20 nM (z5000- noggin in the absence of cold competitor (5100% spe-
fold excess) unlabeled BMP4; both methods gave ap- cific binding).
proximately equal background levels. BMP4 and BMP2 effectively competed with 125I-BMP4
Following subtraction of nonspecific binding, copreci- for binding to noggin, while BMP7 bound less tightly
pitating BMP4 counts were normalized with respect to and TGFb not at all (Figure 4). BMP2 and 24 are very
the specific activity of 125I-BMP4 at each total BMP4 closely related, so it is not surprising that both bind
concentration to determine the absolute concentrations noggin. The observation that low picomolar concentra-
of bound and free ligands (Figure 3). Scatchard analysis tions of unlabeled BMP4 inhibit >50% of the 125I-BMP4
of these data produces an apparent Kd of 19 pM. The binding detected is consistent with the very high affinity
other known TGFb-binding protein, follistatin, has a suggested by Scatchard analysis. BMP7, despite its re-
comparable affinity for its target, activin (1.3–200 pM; duced affinity relative to BMP4, is coexpressed with
Nakamura et al., 1990; Schneyer et al., 1994). This strik- noggin in the organizer and might still experience some
ingly high affinity suggests that noggin could effectively binding in vivo. A concentrated COS cell supernatant of
compete with cell-surface receptors for binding to BMP myc-tagged activin also did not compete at nanomolar
ligands. concentrations, but the data are not strictly comparable
since the activin was not purified (data not shown). Puri-
fied TGFb1 does not compete with BMP4 for binding,Specificity of noggin–BMP Interactions
While BMP4 has been the most-studied of the BMPs demonstrating that noggin can discriminate among re-
lated proteins.in Xenopus embryogenesis, related activities, such as
BMP2 and BMP7/OP-1, have been identified (Plessow
et al., 1991; Nishimatsu et al., 1992); other TGFb family noggin Prevents BMP4 from Binding Its Receptors
Having determined that noggin binds BMP4 very tightly,members, such as activin and Vg-1, appear to play very
different roles (Kessler and Melton, 1994; Slack, 1994). we wished to describe the mechanism by which it
blocked BMP4 activity. We used an affinity-labelingTo test whether noggin interacted specifically with
BMP4 or whether it could bind a range of TGFb family assay to distinguish between the following alternatives:
first, the noggin-BMP4 complex binds BMP4 receptorsmembers, we incubated trace 125I-BMP4 with Fc-tagged
human noggin and a range of concentrations of unla- normally (but fails to initiate normal signaling), or sec-
ond, the noggin-BMP4 complex fails to bind BMP4 re-beled TGFbs. BMP4, BMP2 (92% amino acid homology
to BMP4), BMP7 (58%), and the more distantly related ceptors.
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and 5B1, did not significantly affect noggin activity (Fig-
ure 6A). Antibodies alone had no effect on explants.
MAb1A4’s effects were specific for Xenopus noggin,
since induction of muscle actin by human noggin protein
or by injection of mRNAs encoding two alternative dor-
salizing agents—chordin and a dominant negative BMP
receptor—was not inhibited by the presence of this anti-
body (Figure 6D).
We then compared the blocking antibody, MAb1A4,
with the nonblocking antibodies 2C3 and 5B1 for theirFigure 5. Preincubation with noggin Prevents BMP4 from Binding
ability to immunoprecipitate a noggin-BMP4 complex.Its Receptors
A 50-fold molar excess of each antibody was preincu-2.5 nM 125I-BMP4 was preincubated with or without 50 nM purified
human noggin, then allowed to bind to COS7 cells that had been bated with noggin protein for 1 hr prior to the addition
transfected with pCMV5-BMPRII-His (lanes 1 and 2), pCMV5- of 125I-BMP4. All three antibodies precipitated approxi-
BMPRI-HA (lanes 7 and 8), both (lanes 3, 4, 9, and 10), or pCMV5 mately equal amounts of noggin protein as measured
alone (vector) (lanes 5, 6, 11, and 12), and chemically cross-linked
by western blot; however, the blocking antibody 1A4with BS3. Lanes 1–6 were precipitated using the His tag on the type
coprecipitated significantly less 125I-BMP4 (Figure 6B).II BMP receptor; lanes 7–12 with the HA tag on the type I BMP
Quantitation of noggin and BMP4 in a separate experi-receptor. 125I-BMP4 alone affinity-labeled either receptor type (lanes
1 and 7, hatched arrows); binding was enhanced by cotransfection ment indicates that the blocking antibody precipitates
of both receptors (lanes 3 and 9). Receptor-transfected cells were 15-fold less BMP4 per unit of noggin than do the other
also enriched for binding of 125I-BMP4 monomer (closed arrows) and antibodies (Figure 6C). The most likely explanation is
crosslinked dimer (single-headed arrow). No binding was detected that the antibody that blocks noggin’s biological activity
in the absence of transfected receptors (vector alone, lanes 5, 6,
in the ventral marginal zone assay does so by binding11, and 12). The presence of 20-fold excess noggin in the preincuba-
to and occluding the face of noggin that interacts withtion step abolished affinity labeling of receptor complexes (lanes 2,
4, 8, and 10) as well as coprecipitation of 125I-BMP4 monomer and BMPs. Antibodies that do not block activity presumably
dimer. bind elsewhere onnoggin, and can therefore coimmuno-
precipitate the complex. The small amount of BMP4
coprecipitated by the blocking antibody may result from
immune complexes formed in which only one subunitWe transfected COS cells with expression constructs
of the noggin dimer is bound by antibody, leaving thecontaining either or both of the type I and II BMP recep-
other subunit free to bind BMP4.tors bearing influenza virus haemagglutinin (HA) epitope
We have also reproduced in Xenopus the results ofand histidine (his) tags, respectively (Liu et al., 1995).
Holley et al. (1996), by showing that injected nogginThe use of different tags enabled us to assay binding
RNA fails to dorsalize embryos or neuralize animal capsto the two receptor types independently. 125I-BMP4 was
coinjected with a constitutively active mutant BMP re-preincubated for 1 hr with or without a 100-fold molar
ceptor RNA (Hoodless et al., 1996) (L. Z., D. Hsu, andexcess of purified human noggin protein, then allowed
R. M. H, data not shown). These results complementto bind to transfected COS monolayers, washed, and
the biochemical data, which predict that an activatedchemically crosslinked. Receptor-125I-BMP4 complexes
receptor would be epistatic to activities outside the cell.were precipitated from cell extracts using either of the
Together with ourantibody analysis showing that nog-tags on the receptors, and visualized by SDS–PAGE and
gin’s biological activity correlates with its ability to bindautoradiography (Figure 5). noggin protein abolished
BMPs, these observations strongly suggest that noggin125I-BMP4 labeling of both type I and type II receptors,
acts via a direct BMP-binding mechanism in vivo.indicating that BMP4 complexed with noggin is not ca-
pable of binding its receptors.
Discussion
An Antibody That Blocks noggin’s Biological We propose a model in which secreted noggin mediates
Activity Also Blocks BMP4 Binding aspects of Spemann organizer function by blocking in-
The ability to bind to BMP proteins, prevent them from tercellular BMP signaling. In vivo, noggin expressed in
interacting with their receptors, and block their activities the dorsal tissues of developing embryos may combat
in a bioassay strongly suggests that noggin exerts its ventralizing signals, and help to unmask expression of
inductive activities in the Xenopus embryo via a direct neural or dorsal mesodermal markers. In explant assay
BMP-binding mechanism. We tested this hypothesis by systems, noggin may inactivate a reservoir of BMP pro-
asking whether reagents that block noggin’s biological tein trapped on the cell-surface and in extracellular ma-
activity in a Xenopus explant assay could also interfere trix. Dissociated cells from animal cap explants can be
with the formation of a noggin-BMP complex. neuralized by noggin treatment, but they also “autoneu-
A panel of anti-Xenopus noggin monoclonal antibod- ralize” if dispersed for 4 hr, consistent with a slow loss
ies was generated and screened for the ability to inhibit of a signal from the cell surface. Treatment with BMP4
dorsalizationof ventralmarginal zones by noggin protein suppresses autoneuralization and restores the epider-
(Smith et al., 1993). One antibody, MAb1A4, was shown mal phenotype characteristic of intact caps (Wilson and
to be effective in blocking induction of muscle actin Hemmati-Brivanlou, 1995). The large dose of exogenous
noggin protein required to neuralize animal caps (Lambby Xenopus noggin; several others, including MAbs2C3
noggin Binds BMP4 with High Affinity
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et al., 1993) is also consistent with the proposed mecha-
nism, since the noggin must diffuse into intercellular
spaces to block the BMP signals. While the data pre-
sented here do not formally disprove the existence of
an independent noggin signal transduction system, they
do provide a rationale for most of noggin’s observed
effects. Efforts to describe a cell-surface noggin recep-
tor, including binding assays, biochemical approaches,
and expression screens, have not uncovered evidence
for a more conventional noggin-binding component
(L. B. Z., R. M. H., A. Economides, N. Stahl, unpublished
data).
While noggin binds BMP2 and 24 with very high affin-
ity, other TGFb family members with which noggin may
interact continue to be identified in thedeveloping Xeno-
pus embryo. Several of these have ventralizing activities
similar to BMP4’s, yet are expressed in the dorsal re-
gions from which BMP4 is excluded. Repression of ven-
tralizers in these regions during gastrulation is poten-
tially more critical to the embryo than elimination of
diffusing BMP4 activities. Our data suggest that BMP7
has a lower affinity for noggin, but at higher concentra-
tions can compete away BMP4 binding. BMP7 is also
capable of forming a highly active heterodimer with
BMP4 (3–10 times more active than either BMP4 or 27
homodimers (Aono et al., 1995) that could also be sub-
ject to regulation by noggin. Another BMP-related mole-
cule, anti-dorsalizing morphogenetic protein (ADMP), is
expressed specifically in the organizer, yet ventralizes
embryos when injected dorsally, in its normal site of
expression (Moos et al., 1995). While not closely related
to BMP2 and 24, ADMP is a candidate target for inacti-
vation by noggin by virtue of its apparently contradictory
organizer-specific expression and robust ventralizing
activity. The involvement of diverse homo- and hetero-
dimeric BMP activities, counteracted by noggin and po-
tentially other organizer-secreted factors with distinct
specificities, such as chordin and follistatin (Hemmati-
Brivanlou et al., 1994; Sasai et al., 1994), suggests that
dorsoventral axis formation may be regulated with con-
Figure 6. Antibody Inhibition of noggin Activity and noggin-BMP4 siderable redundancy and specificity.
Complex Formation Detection and quantitation of endogenous noggin and
(A) Antibody inhibition: ventral marginal zones of stage 10.5 Xenopus BMP proteins in the embryo remains problematic. The
embryos were dissected and incubated in control medium or me-
very high affinity of noggin for BMP2 and 24 suggestsdium containing 150 nM monoclonal anti-noggin antibody 1A4, 2C3,
these molecules are likely to interact where coex-or 5B1 with or without 3.3 nM Xenopus noggin protein; RNA was
pressed. Effects where expressing cells are separated,then harvested at stage 24 and subjected to reverse transcription–
PCR for the dorsal marker muscle actin and EF1a. Anti-noggin anti- or on other BMPs and TGFb family members, are more
body 1A4 blocked noggin’s ability to induce muscle actin, while difficult to predict. Recent evidence has suggested that
antibodies 2C3 and 5B1 did not. Antibodies alone had no effect in the Drosophila BMP2/-4 homolog decapentaplegic may
this assay. act as a morphogen during wing formation, eliciting dis-
(B) Coimmunoprecipitation using anti-noggin monoclonal antibod-
tinct cellular responses as it diffuses away from itsies: MAb’s1A4, 2C3, and 5B1 were incubated with noggin alone,
source (Nellen et al., 1996). noggin that is overexpressed125I-BMP4 alone, or noggin plus 125I-BMP4. All three antibodies pre-
in RNA-injected Xenopus embryos can also diffusecipitate approximately the same amount of noggin protein as de-
tected by Western blot, but MAb 1A4 fails to coprecipitate significant (J. D. J. and R. M. H., unpublished data), but diffusion
125I-BMP4. may only occur when low affinity binding sites in the
(C) Quantitation of coimmunoprecipitation: 125I-BMP4 signal from extracellular matrix are saturated by excess noggin.
each immunoprecipitation was quantitated on a phosphoimager,
noggin does bind heparin, which suggests such an asso-then normalized to the noggin Western blot signal for the same
ciation with extracellular matrix (L. B. Z. and R. M. H.,precipitation to give the amount of 125I-BMP4 precipitated per unit
noggin. MAbs 2C3 and 5B1 coprecipitate 5- to 20-fold more 125I-
BMP4 than does MAb 1A4.
(D) Blocking MAb1A4 is specific for Xenopus noggin: ventral mar- chordin mRNA or 2 ng of a dominant-negative BMP receptor mRNA
ginal zones were treated essentially as in (A), except that explants (DN-BMPR) at the two cell stage. MAb 1A4 specifically blocked
were also treated with purified human noggin protein (H-noggin) or the dorsalizing effects of Xenopus noggin but not human noggin,
were dissected from embryos that had been injected with 0.5 ng chordin, or DN-BMPR.
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cleaved during maturation, resulting in a myc-tagged BMP4 mole-unpublished data). In any case, noggin is likely to affect
cule of the expected size (Aono et al., 1995). PCR primers: 59:BMP activity gradients by acting as a sink for diffusible
BMP4myc(S): GCTG ATA TCC GAG GAG GAC CTG AAA CAT TGCBMPs.
CGG AGG CAT TC; 39: B4MC-D: CG CTC GAG TCA ACG GCA CCC
BMP activity may be subject to quenching by noggin ACA CCC (gift of Paul Wilson). This construct, pMT21BMP4myc(s),
in several embryonic tissues. noggin displays a complex was then transfected into COS cells using lipofectamine (GIBCO–
BRL, Gaithersburg, Maryland), and the supernatants were quanti-pattern of expression later in embryogenesis, notably
tated by Western blot with reference to known amounts of myc-in developing skeleton and central nervous system
tagged noggin as well as by biological activity in Xenopus explant(L. B. Z., R. M. H., L. Brunet, S. Takada, J. A. McMahon,
assays (Dale et al., 1992). To construct Fc-tagged noggin, an SrfI–and A. P. McMahon, unpublished data). BMPs are widely
NotI human IgG1 fragment (Davis et al., 1994; Economides et al.,
coexpressed with noggin in the developing skeleton. In 1995) was fused to human noggin using an oligonucleotide encoding
the spinal cord, noggin is expressed in the roofplate the following peptide bridge sequence to incorporate the SrfI site:
(noggin)... SECKCSC (end)- VAAGPGG (bridge)- EPKSCDKTHTCPP(Smith and Harland, 1992, and unpublished data). BMP
CPAP (hinge of human IgG1); this construct has specific activitysignaling has been implicated in the differentiation of
indistinguishable from wild-type frog or human noggin proteins indorsal cell types in the chick neural tube, with BMP4
Xenopus explant assays (data not shown). Fc-tagged human nogginand 27 expressed in the dorsal neural tube and the
was purified from COS supernatants and untagged human noggin
adjacent epidermal ectoderm, respectively (Liem et al., was purified from baculovirus-infected insect cells as previously
1995). noggin could also modulate a later role for BMP2 described (Lamb et al., 1993), and were the gift of Regeneron Phar-
maceuticals Inc., Tarrytown, New York. myc-tagged activin-condi-in instructing neural crest cells to differentiate into neu-
tioned medium was made by transfection of COS cells with therons (Shah et al., 1996). In the mediolateral patterning
plasmid pKB590 (a gift of K. Basler and T. Jessell, Columbia Univer-of somites, an unidentified signal from the neural tube
sity). TGFb1 purified from porcine platelets was purchased from R&has been shown to antagonize BMP4 secreted by the
D Systems, Minneapolis, Minnesota.
lateral plate (Pourquie et al., 1996). BMP7 has also been
shown to induce dendritic growth in rat sympathetic Sepharose-noggin Preparation and BMP4myc Binding Assay
neurons (Lein et al., 1995); noggin, which has a complex Xenopus noggin was purified from COS supernatants as previously
described (Lamb et al., 1993) and coupled to CNBr-activated sepha-patternof expression in thedeveloping brain (Valenzuela
rose 4B (Pharmacia Biotech, Uppsala, Sweden) according to theet al., 1995), could be involved in modulation of neurite
manufacturer’s instructions. Mock-coupled beads were exposed toarborization. In addition to its normal role in animal de-
an identical coupling and blocking protocol in the absence of nogginvelopment, noggin may also prove a useful pharmaco-
protein. Ten microliters of noggin- or mock-coupled beads were
logical reagent with which to manipulate BMP signaling then incubated with 250 microliters of BMP4myc COS supernatant
in a variety of systems. (z0.2 mg/ml BMP4) and 1 mg/ml gastrula extract in 1 ml of binding
buffer (20 mM HEPES [pH 7.6], 10 mM MgCl2, 300 mM NaCl, 0.1Here we describe a mechanism by which noggin may
mM PMSF, 5 mg/ml leupeptin, and 0.1% CHAPS) for 2 hr at 48C.participate in Spemann organizer function. Do the rest
Beads were then washed three times in 1 ml of binding buffer, boiledof the candidate secreted organizer molecules act simi-
in sample buffer, and then subjected to Western analysis with 9E10larly, or on different pathways? Other treatments that
anti-myc monoclonal antibody.
induce neural tissue in Xenopus include expression of
dominant negative activin and BMP receptors, both of Affinity Labeling and Precipitation of BMP Receptors
which block the BMP signaling pathway, and injection Radiolabeling of BMP4 was performed using Iodo-Beads (Pierce),
with slight modifications. In brief, one iodobead was washed inof mRNAs encoding chordin or the other known TGFb-
phosphate-buffered saline (PBS), then incubated 59 at room temper-binding protein, follistatin (Hemmati-Brivanlou et al.,
ature with 5 ml (500 mCi) 125I-NaI in 445 ml of PBS. Two micrograms1994). Chordin appears to be the homolog of the Dro-
of BMP4 was brought to 50 ml in 10 mM acetic acid, mixed with thesophila secreted factor short gastrulation, which antag-
reacting iodobead, and incubated for 59 at room temperature and
onizes decapentaplegic (Holley et al., 1995; Sasai et al., 59 on ice. The iodobead was then removed, carrier protein (BSA)
1995). While neither follistatin nor chordin bear signifi- was added to 1 mg/ml, and the solution was desalted over Pierce
GF-5 columns according to the manufacturer’s instructions.cant sequence similarity to noggin or each other, both
COS-7 cells were maintained in Dulbecco’s modified Eagle’s me-may have the potential to act by binding BMPs. It is an
dium (GIBCO–BRL) supplemented with 10% fetal bovine serumattractive possibility that many of the Spemann organiz-
(DME 10%), transfected with lipofectamine and pCMV5-BMPRII-er’s long-studied instructive properties may result from
His, pCMV5-BMPRI-HA, or pCMV5 (kind gifts of Joan Massague´,
its ability to prevent other instructions, specifically ven- Columbia University) and subjected to binding 36 to 48 hr later.
tralizing BMP-like signals, from reaching their targets. Whole cell binding and affinity labeling were performed using
established procedures (Massague´, 1987), except that a protease
inhibitor cocktail (0.1 mM PMSF, 0.5 mg/ml leupeptin, pepstatin,
chymostatin, aprotinin, and antipain) was added during the preincu-Experimental Procedures
bation and binding procedures to decrease nonspecific binding
(Koenig et al., 1994). In brief, z2.5 nM 125I-BMP4 was preincubatedDesign and Purification of Proteins
Purified recombinant human BMP2, 24, and 27 were the kind gift of for 1 hr with or without 50 nM purified human noggin in binding
buffer (128 mM NaCl, 5 mM KCl, 5 mM MgSO4, 1.2 mM CaCl2, 50 mMGenetics Institute, Cambridge, Massachusetts. myc-tagged BMP4
protein was generated by using polymerase chain reaction (PCR) HEPES [pH 7.8], 2 mg/ml BSA) prior to binding to cell monolayers in
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